INTEST CORP
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 13, 2025
INTT$13.66+2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. PROPERTIES
As of December 31, 2024, we leased fourteen facilities worldwide. The following chart provides information regarding each of our principal leased facilities as of December 31, 2024:
| Location | Lease Expiration | Approx. Square Footage | Principal Uses |
|---|---|---|---|
| Rochester, NY | April 2028 | 79,150 | Process Technologies segment operations (principal facility for Ambrell®) |
| Mansfield, MA | February 2032 | 58,800 | Environmental Technologies segment operations (principal facility for iTS), Process Technologies segment operations (principal facility for Videology®) |
| Milan, Italy | February 2030 | 51,871 | Electronic Test segment operations (principal facility for Alfamation™) |
| Mt. Laurel, NJ | April 2031 | 33,650 | Corporate headquarters and Electronic Test segment operations |
| Penang, Malaysia | May 2027 | 25,000 | Applications engineering, product development and localized manufacturing for nearly all inTEST brands |
| Markham, Ontario, Canada | February 2028 | 16,437 | Electronic Test segment operations (principal facility for Acculogic Inc.) |
All of our facilities have space to accommodate our needs for the foreseeable future.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.